financetom
Business
financetom
/
Business
/
AerCap Signs Sale and Leaseback Agreement for Boeing 787-9 with TAAG Angola Airlines to Support Fleet Modernization
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AerCap Signs Sale and Leaseback Agreement for Boeing 787-9 with TAAG Angola Airlines to Support Fleet Modernization
Dec 27, 2024 9:17 AM

On Friday, AerCap Holdings N.V. ( AER ) announced that it has entered into a sale and leaseback agreement with TAAG Angola Airlines for one new Boeing Company ( BA ) 787-9 aircraft.

The aircraft is set to be delivered to TAAG in February 2025 as part of the airline's ongoing fleet modernization efforts.

This transaction marks a significant milestone, as AerCap ( AER ) becomes the first lessor to introduce the Boeing 787 to TAAG.

Aengus Kelly, CEO of AerCap ( AER ), expressed enthusiasm about the new partnership, highlighting that the 787-9 will help TAAG expand its network across Africa, Europe, and Asia with one of the most fuel-efficient widebody aircraft available.

"As part of their fleet modernization program, the 787 will enable TAAG expand their network across Africa, Europe and Asia with one of the most fuel-efficient widebody aircraft on the market and support them in meeting customer demand," said Kelly.

Also Read: US Stocks To Open Lower As Index Future Decline: Analysts Remain Upbeat About Santa Rally

The aircraft's advanced technology and efficiency will support TAAG's growth and improve its ability to meet increasing customer demand.

The introduction of the Boeing 787-9 will also help TAAG optimize operational costs while offering greener environmental mobility solutions.

Earlier in December, AerCap ( AER ) signed lease agreements for two Boeing 737-800 aircraft. Mukamalah Aviation Company, a subsidiary of Aramco, will operate the aircraft to transport Aramco Group passengers in Saudi Arabia.

This further underscores AerCap's ( AER ) expanding presence in the aviation leasing market.

Price Action: AER shares are trading lower by 0.31% to $95.17 at the last check on Friday.

Read Next:

S&P 500 Hits 57 All-Time Highs In Record-Breaking 2024: Magnificent 7 Drive 30% Of Nasdaq's Surge

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Top Premarket Decliners
Top Premarket Decliners
Jun 25, 2025
08:04 AM EDT, 06/25/2025 (MT Newswires) -- Torrid Holdings ( CURV ) shares were 29% lower pre-bell Wednesday after the company said late Tuesday it priced a secondary stock offering at $3.50 per share. Allot (ALLT) shares were down 15%, a day after the company priced a $40 million stock offering. Forte Biosciences ( FBRX ) stock was down 9%...
Energy Transfer expands its LNG supply agreement with Chevron
Energy Transfer expands its LNG supply agreement with Chevron
Jun 25, 2025
June 25 (Reuters) - Energy Transfer ( ET ) said on Wednesday it had signed a sale and purchase agreement with U.S. oil major Chevron ( CVX ) for additional LNG supply from its Lake Charles LNG export facility. ...
Plus Therapeutics Says FDA Clears Reyobiq IND Application for Pediatric Brain Cancer; Shares Up Pre-Bell
Plus Therapeutics Says FDA Clears Reyobiq IND Application for Pediatric Brain Cancer; Shares Up Pre-Bell
Jun 25, 2025
08:06 AM EDT, 06/25/2025 (MT Newswires) -- Plus Therapeutics ( PSTV ) said Wednesday that the US Food and Drug Administration has cleared its investigational new drug application for Reyobiq, paving the way for a phase 1/2a trial targeting pediatric patients with recurrent or progressive high-grade glioma and ependymoma. The company said the trial, which will assess safety, maximum tolerated...
Copyright 2023-2026 - www.financetom.com All Rights Reserved